Navigation Links
Amerinet Awards Contract to Instrumentation Laboratory for Critical Care Portfolio
Date:2/1/2010

BEDFORD, Mass., Feb. 1 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has been awarded a three-year contract for its critical care portfolio with Amerinet Inc., a leading health care group purchasing organization.  This is the third consecutive contract Amerinet has awarded IL since 2001.

The contract offers more than 37,000 Amerinet members savings on IL's portfolio of critical care analyzers, reagents, consumables and service, including IL's flagship product, the GEM® Premier™ 4000 analyzer for blood gas, CO-Oximetry, electrolyte and metabolite testing.  This analyzer features Intelligent Quality Management (iQM®), a real-time, automated, continuous quality assurance system that ensures the quality of every test result and reduces cost and time expenditure.  iQM, coupled with its cartridge-based technology and ease of use, allows the GEM Premier 4000 to be used throughout the hospital, at the point of care and in the lab.  

"Amerinet understands how important a healthy operating margin is for every health care provider.  That's why we partner with all types of providers to create new revenue streams and reduce expenses," said Ken Rosemann, Vice President, Laboratory and Diagnostic Imaging for Amerinet.  "This new agreement is one example of our commitment to quality.  Over the past nine years, IL has delivered outstanding products and service to Amerinet's members."

"We will continue to provide Amerinet members with savings on the best in critical care diagnostic products," said Brian Durkin, Director Sales and National Accounts at IL.  "Our ever-improving and expanding product offering will help Amerinet members stay at the forefront of technology and deliver the highest quality patient care."  

In addition to the GEM Premier 4000, IL's contract with Amerinet includes the GEM Premier 3500, GEM OPL, a portable CO-Oximeter; GEMweb, software for remote management of instruments; and GEMweb Plus™, a completely integrated data management system.

About Amerinet

As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.

About IL

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories.  The company's product lines include critical care systems, hemostasis systems and information management systems.  IL's GEM® product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM®), GEM Premier™ 4000 analyzer, GEMweb Plus information management system, and the GEM PCL Plus, a portable coagulation analyzer.  IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP, the new ACL TOP LAS and the ACL TOP 500 CTS.  IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents.  IL is based in Bedford, Massachusetts.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions.  All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.

SOURCE Instrumentation Laboratory

RELATED LINKS
http://www.ilus.com

'/>"/>

SOURCE Instrumentation Laboratory
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings
2. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
3. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
4. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
5. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
6. Small Business Innovation Research Program Awards Grant to Biomoda
7. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
8. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
9. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
10. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
11. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Schweiz, April 27, 2016 ... CEO Forums in Zürich gab Strekin AG ... Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens von ... bekannt. Für die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe ... angeworben. STR001 wird während der Operation direkt ...
(Date:4/27/2016)... , April 27, 2016   Zillion ... its digital health technology platform, which specializes in ... programs into scalable digital products, Zillion enables companies ... and empower consumers to take control of their ... live video conferencing – including one-to-one, group and ...
(Date:4/27/2016)... 2016 Oasmia Pharmaceutical AB ... a new generation of drugs within human and ... for Paclical/Apealea in the Phase III study that ... ovarian cancer. These preliminary results showed non-inferiority between ... carboplatin versus Taxol in combination with carboplatin. In ...
Breaking Medicine Technology:
(Date:4/30/2016)... (PRWEB) , ... May 01, 2016 , ... Serenity Recovery, ... to rehabilitation, has produced a new video that focuses on one of the more ... recent sessions and clips from interviews with a participating patients and the Yoga class ...
(Date:4/30/2016)... ... April 30, 2016 , ... Saturday, April 30, marks ... impact on public health. The World Veterinary Association (WVA) and the World Organization ... selected continuing education with a One Health focus, which emphasizes how veterinarians pursue ...
(Date:4/30/2016)... , ... April 30, 2016 , ... Orlando-based Maximized Living ... they go for gold in Rio. Under the care of Maximized Living doctors ... , In an unprecedented showing, Maximized Living is sending the largest contingent of elite ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Footwear Foundation, the national charitable foundation serving the footwear industry, has broken all ... representing more than 130 companies across 23 states during the months of April ...
(Date:4/29/2016)... , ... April 29, 2016 , ... On Tuesday, April ... across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the ... Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations which ...
Breaking Medicine News(10 mins):